pH News and Research

RSS

pH comes from the term “power of Hydrogen”, or the hydrogen ion concentration present in a given solution. It helps to measure the acidity or alkalinity of a substance.

PharmaNet Development to display innovative solutions at 2009 AAPS Annual Meeting and Exposition

PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, today announced that the Company and its subsidiaries Anapharm and Taylor Technology will be showcasing a range of innovative solutions at the 2009 AAPS Annual Meeting and Exposition.

13 Oct 2009

A new site and blog for dieters to share information launched by DietReality.com

In response to an increasing need to provide up-to-date information on safe and effective weight loss products, DietReality.com has launched a new site and blog designed to empower dieters to share information.

12 Oct 2009

Wake Forest University School of Medicine honours researchers

Wake Forest University School of Medicine honored eight of its researchers with awards for excellence at the 13th Annual Research Awards Day Oct. 1.

12 Oct 2009

Breathe Easy, Stay Healthy Campaign for reducing toxic air pollution in Pittsburgh

Today, Citizens for Pennsylvania’s Future (PennFuture), joined by leaders from the Group Against Smog and Pollution (GASP) and Clean Water Action, along with Dr. Evelyn O. Talbott of the University of Pittsburgh Graduate School of Public Health Department of Epidemiology and Allegheny County Council President Richard Fitzgerald, announced a major new campaign to reduce the fine soot pollution responsible for Pittsburgh’s number one ranking for dirtiest air for two years running.

9 Oct 2009

Daily doses of imatinib mesylate double survival rates in Ph+ ALL affected children

Results of a phase two clinical trial published October 5th in the Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).

7 Oct 2009

Americans are not getting correct drug information, says study

Do consumers truly understand how to take their medications and the possible side effects and interactions that can occur as a result? Though the vast majority of study respondents who have recently picked up a prescription drug say they understand how to take their medication (90%), only 60% are aware of the potential interactions with other prescribed medication, and only 58% are aware of interactions with OTC medication they are taking, according to the latest ‘Under the Skin’ survey by ORC Guideline, an infoGROUP company.

3 Oct 2009

TheraDoc's patient safety surveillance system helps hospitals manage their H1N1 responses effectively

As the battle against the H1N1 influenza outbreak continues, hospitals are on the front lines, charged with identifying, treating, monitoring, and reporting flu cases—as well as preventing their spread to other patients and hospital personnel. To facilitate this arduous task, a growing number of U.S. hospitals are using a patient safety surveillance system developed by TheraDoc that helps them more effectively coordinate their responses to this serious public health threat.

30 Sep 2009

Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate

Emergent BioSolutions Inc. announced today that it was awarded a cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to further the development of one of Emergent’s advanced anthrax vaccine candidates known as dmPA7909.

30 Sep 2009

U.S. troops use the Infectiguard Hand Sanitizer

Combating germs just took on a whole new meaning. Infectiguard Hand Sanitizer from Dr. Fresh Inc. has begun active duty as hand sanitizer to U.S. troops worldwide. The line of hand sanitizer products known for effectively killing germs without harsh drying effects to the hands will be offered at all Army and Airforce bases across the globe, just in time for what experts promise will be a particularly early and difficult cold and flu season. www.infectiguard.com

28 Sep 2009

Laureate Pharma sign development and manufacturing agreement with ZZ Biotech

Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has entered into a development and manufacturing agreement with ZZ Biotech, LLC. According to the agreement, Laureate will produce Activated Protein C variant under cGMP conditions. Terms of the manufacturing agreement were not disclosed.

28 Sep 2009

Seven-year program launched to combat maternal, infant mortality in the Philippines

The Philippines' Department of Health (DOH) on Friday - in partnership with UNICEF, the U.N. Population Fund (UNFPA), the WHO and the Australian Agency for International Development (AusAID) - launched a seven-year program aimed at reducing maternal and infant mortality rates, the Philippine Star reports.

21 Sep 2009

H1N1 infected people continue to shed live virus days after the symptoms

ABC News and other outlets are reporting that two studies released on Tuesday suggest that people infected with the H1N1 virus continue to shed virus after the point where current recommendations say they can resume their normal activities.

19 Sep 2009

AMR finds 75 percent of hetastarch recipients underwent surgical procedures

Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that for the January - May 2009 time period, a significantly higher percentage of hetastarch recipients (75%) underwent a surgical procedure when compared to those receiving albumin/plasma protein fraction (51%).

19 Sep 2009

CI Index of ten leading cancer immunotherapy stocks increase by 58% in two months

The Cancer Immunotherapy Index of ten leading cancer immunotherapy stocks has increased 58% in its first two months of reporting. CI Index gain was paced by the 233% share price improvement of ImmunoCellular Theraputics, Inc. (IMUC.OB) under the leadership of CEO Manish Singh, Ph. D.

17 Sep 2009

Keryx Biopharmaceuticals receives orphan-drug designation for a multiple myeloma drug

AEterna Zentaris Inc., ("the Company") a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that Keryx Biopharmaceuticals, Inc., its partner and licensee for perifosine in the North American market, has received orphan-drug designation for this compound from the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma.

16 Sep 2009

Concept of wellness can yield greater savings

According to a new survey released today, 90 percent of plan sponsors believe that minimal attention to personal health and increased incidence of chronic illness such as diabetes and heart disease are at the root of rising health care costs.

14 Sep 2009

Quatrx' second phase 3 study of ospemifene tablets provides positive results

QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).

10 Sep 2009

Genomic technologies to improve wine production techniques

While the art of fine winemaking is a beautiful thing, winemakers are increasingly turning to the power of science to give them the tools they need to ensure a high quality pour each and every time.

10 Sep 2009

Majority of Americans are complacent about problems with their health plans: Study

Having problems with your health plan? If you speak up about it — or move on to another plan — you are a very unusual consumer, according to a new study.

9 Sep 2009

URV’s biosensor can detect typhoid causing bacteria instantly

A research group from the Rovira i Virgili University (URV) in Tarragona has developed a biosensor that can immediately detect very low levels of Salmonella typhi, the bacteria that causes typhoid fever. The technique uses carbon nanotubes and synthetic DNA fragments that activate an electric signal when they link up with the pathogen.